Lexaria Bioscience (LEXXW) Competitors $0.33 -0.02 (-5.71%) As of 02/21/2025 03:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends LEXXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Lexaria Bioscience stock or one of its competitors? The main competitors of Lexaria Bioscience include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Lexaria Bioscience vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Lexaria Bioscience (NASDAQ:LEXXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Which has stronger earnings and valuation, LEXXW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLexaria Bioscience$496.92KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is LEXXW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Lexaria BioscienceN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the media favor LEXXW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Lexaria Bioscience. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Lexaria Bioscience. 180 Life Sciences' average media sentiment score of 1.38 beat Lexaria Bioscience's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Lexaria Bioscience Neutral 180 Life Sciences Positive Does the MarketBeat Community prefer LEXXW or ATNFW? Lexaria Bioscience and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformLexaria BioscienceN/AN/A180 Life SciencesN/AN/A Summary180 Life Sciences beats Lexaria Bioscience on 2 of the 3 factors compared between the two stocks. Get Lexaria Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for LEXXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LEXXW vs. The Competition Export to ExcelMetricLexaria BioscienceBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$118.00M$5.84B$9.15BDividend YieldN/A3.69%4.75%3.85%P/E RatioN/A3.2026.1519.13Price / SalesN/A4,826.69435.3370.72Price / CashN/A13.0138.0134.83Price / BookN/A47.077.644.62Net IncomeN/A-$87.82M$3.19B$245.94M7 Day Performance-2.94%0.38%-2.11%-2.62%1 Month Performance-32.65%3.67%-0.49%-2.15%1 Year Performance-57.42%99.17%16.44%12.95% Lexaria Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LEXXWLexaria BioscienceN/A$0.33-5.7%N/A-58.8%$0.00$496,923.000.007Gap UpHigh Trading VolumeATNFW180 Life SciencesN/A$0.01+10.8%N/A+51.5%$0.00N/A0.007News CoveragePositive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03+7.6%N/A-13.4%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.15flatN/A+138.5%$0.00$40,633.000.0040Gap DownALVOWAlvotechN/A$2.20-8.3%N/A-46.2%$0.00$391.87M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/A-54.4%$0.00N/A0.004BFRIWBiofronteraN/A$0.06-6.3%N/A+254.1%$0.00$35.36M0.0070High Trading VolumeBTMDWbioteN/A$0.50flatN/A-46.2%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12+0.2%N/A-92.9%$0.00N/A0.008Gap DownCELUWCelularityN/A$0.07flatN/A+120.8%$0.00$48.20M0.00220Gap Up Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Celularity Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LEXXW) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
